1. Adam, W. R., and Dawborn, J. K., 1970, Urinary excretion and plasma levels of sulfonamides in patients with renal impairment, Aust. Ann. Med. 19: 250.
2. Anderson, R. J. Gambertoglio, J. G., and Schrier, R. W., 1976a, Clinical Use of Drugs in Renal Failure,Charles C. Thomas, Springfield, Illinois.
3. Anderson, R. J., Gambertoglio R., and Schrier R. W., 1976b, Fate of drugs in renal failure, in: The Kidney ( B. Brenner and F. Rector, eds.), pp. 1911–1948, W. B. Saunders, Philadelphia.
4. Andrew, O. T., Schoenfeld, P. Y., Hopewell, P. C., and Humphreys, M. H., 1980, Tuberculosis in patients with end stage renal disease, Am. J. Med. 68: 59.
5. Aoki, F. Y., Sitar, D. S., and Ogilvie, R. I., 1979, Amantadine kinetics in healthy young subjects after long term dosing, Clin. Pharmacol. Ther. 26: 729.